The European Health Data Space Regulation (EHDS) was adopted by the Council of the European Union on January 21, 2025. It aims to make European health data accessible for research, policymaking, and innovation, with secondary use provisions becoming relevant for life sciences companies in 2029. This regulation focuses on enhancing individual access to their health data and allows for sharing health data for research and other purposes. Companies handling health data must prepare for these upcoming requirements, as they will have significant impacts, creating both opportunities and risks in the life sciences sector.
The EHDS aims to enhance individual access to health data and facilitate its secondary use for purposes such as research and innovation, impacting life sciences companies.
Life sciences companies, including pharma and biotech, must adapt to the EHDS' requirements, which become applicable in 2029, posing both opportunities and challenges.
#european-health-data-space #health-data-regulation #life-sciences #data-strategy #pharmaceutical-industry
Collection
[
|
...
]